We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Use only when other antibiotics are unsuitable
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
Advice and guidance on the health needs of migrant patients from Uruguay for healthcare practitioners.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
FCDO travel advice for Guatemala. Includes safety and security, insurance, entry requirements and legal differences.
Check the tariff classification for articles made of cermet.
HPTs and healthcare practitioners must complete these forms and send them to UKHSA to enable monitoring of diphtheria cases in England.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
Information on cryptosporidium including sources and routes of transmission, symptoms, and general hygiene advice to minimise the spread.
There have been a small number of reports of serious and life-threatening anticholinergic side effects associated with hyoscine hydrobromide patches, particularly when used outside the licence. Healthcare professionals, patients, parents and carers should be aware of the signs and symptoms...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.